OpenResearchAlpha

Rheumatology · 12 Nov 2026

Endothelial IFI16 drives vasculopathy and profibrotic remodeling in systemic sclerosis by activating JAK/STAT signaling

Linlin Huangh-index 0, Lingbiao Wang, Wenjing Ye, Ling Cao, Yi-Nan Li, Tim Filla, Chen Chen, Xiaoxia Zhu, Yu Xue, Fangfang Chen, Yiyun Yu, Xue Yang, Weiguo Wan, Jiucun Wang, Hejian Zouh-index 7

0
Citations
no database records one yet
0
Citations in 2026
so far
7
Leading author's h-index
Hejian Zou, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Objective Systemic sclerosis (SSc) is characterized by a prominent type I interferon (IFN-I) signature, yet the upstream drivers that link this signature to fibrosis remain unclear. This study aims to identify Interferon gamma–inducible protein 16 (IFI16) as an endothelial mediator that contributes to vasculopathy and fibrotic remodeling in SSc. Methods Machine-learning screening of public bulk RNA-seq was applied to identify fibrosis-associated IFN-I regulators. IFI16 expression pattern was validated by scRNA-seq, spatial transcriptomics and immunofluorescence. Functional and pathway analyses were performed in IFI16-overexpressing endothelial cells. Results A machine-learning–based analysis of bulk RNA-seq datasets demonstrated that IFI16 is significantly upregulated in SSc skin and ranks among the IFN-I–associated genes positively correlated with more severe skin fibrosis, shorter non-Raynaud disease duration, and elevated extracellular matrix deposition. Single-cell and spatial transcriptomic analyses revealed the enrichment of IFI16 in endothelial cells, and the co-localization of IFI16 with vasculature was validated by immunofluorescence. IFI16-high endothelial cells exhibited higher IFN activity and enhanced extracellular matrix remodeling. Stimulation with profibrotic or proinflammatory cytokines (IL-6, IL-1β, TGF-β and IFN-⍺) upregulated IFI16 expression in endothelial cells. Gain-of-function experiments showed that IFI16 overexpression impaired endothelial proliferation, migration, and tube formation, while driving the transition of endothelial cells towards mesenchymal cells through JAK-STAT signaling. Inhibition of JAK-STAT signaling reversed IFI16-induced endothelial-mesenchymal transition. Conclusion Collectively, endothelial IFI16 coupled IFN-I signaling to vasculopathy and fibrotic remodeling via JAK-STAT activation, highlighting IFI16 as a promising therapeutic target in SSc vasculopathy and the subsequent fibrosis.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Hejian Zou has the highest h-index among the authors (7).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (15)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.